This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
September 19, 2017
Bonesupport appoints Jerry Chang as Executive Vice President of Research & Development
September 19, 2017
GenSight Biologics integrates the CAC® Small, CAC® Mid and Small and CAC® All-Tradable Euronext indexes
September 14, 2017
Targovax Receives 2017 Nordic Stars Award
September 13, 2017
Onxeo Grants Exclusive Worldwide License of Validive® developed for the treatment of oral severe mucositis to Monopar Therapeutics
September 12, 2017
2017 Half-Year Results
September 11, 2017
Targovax ASA: Three posters presented at ESMO conference
September 11, 2017
Onxeo Announces Top-Line Results from ReLive Phase III Study of Livatag® in Advanced Hepatocellular Carcinoma
September 08, 2017
EBV treatment may be alternative to lung volume reduction surgery for patients with severe emphysema
September 05, 2017
Strongbridge Biopharma plc to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
September 04, 2017
Nordic Nanovector to Present at Pareto Securities’ 8th Annual HealthCare Conference